Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity

Camilla Elefante1, Giulio Emilio Brancati1, Zahinoor Ismail2,3

  • 1Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

PubMed

Insights

Mild Behavioral Impairment (MBI) may signal early cognitive decline. MBI patients showed distinct psychopathology, differing from primary psychiatric disorders and neurocognitive disorders.

Area of Science:

  • Geriatric Psychiatry
  • Neuropsychology
  • Cognitive Neurology

Background:

  • Mild Behavioral Impairment (MBI) is a concept exploring late-onset neuropsychiatric symptoms (NPSs) as potential early indicators of cognitive decline.
  • Understanding MBI's relationship with major neurocognitive disorders (MNDs) and primary psychiatric disorders (PPDs) is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To investigate the prevalence of MBI in a psychogeriatric outpatient setting.
  • To identify differentiating clinical features of MBI compared to MNDs and PPDs.

Main Methods:

  • A cohort of 144 elderly patients from a psychogeriatric outpatient service was assessed.
  • Evaluations included Clinical Global Impression Severity, Brief Psychiatric Rating Scale (BPRS), and Global Assessment of Functioning (GAF).
  • Patients were categorized into PPDs (n=73), MBI (n=40), and MNDs (n=31).

Main Results:

  • MND patients exhibited the highest illness severity, psychopathology scores (BPRS Total, Psychosis, Activation, Negative), and lowest functioning.
  • MBI and PPD groups showed similar illness severity and functioning, but MBI patients had higher BPRS Total and Negative Symptom scores.
  • MBI patients frequently presented with apathy and motor retardation, suggesting potential diagnostic markers.

Conclusions:

  • MBI is a distinct clinical entity within psychogeriatric services, with specific symptom profiles.
  • Apathy and motor retardation may aid in differentiating MBI from PPDs.
  • Further research into these features is warranted for improved differential diagnosis in elderly populations.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
518
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
93
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
596
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
327
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
117